APA (7th ed.) Citation

N, Z., J, K., T, Z., AZ, A., CL, B., S, B., . . . C, G. (2026). Enhanced overall and progression-free survival in advanced melanoma patients undergoing targeted therapy alongside antithrombotic treatment - Insights from a multicenter study involving 1296 patients from the prospective skin cancer registry ADOReg. European journal of cancer (Oxford, England : 1990), 234, 116195. https://doi.org/10.1016/j.ejca.2025.116195

Chicago Style (17th ed.) Citation

N, Zimmermann, et al. "Enhanced Overall and Progression-free Survival in Advanced Melanoma Patients Undergoing Targeted Therapy Alongside Antithrombotic Treatment - Insights from a Multicenter Study Involving 1296 Patients from the Prospective Skin Cancer Registry ADOReg." European Journal of Cancer (Oxford, England : 1990) 234 (2026): 116195. https://doi.org/10.1016/j.ejca.2025.116195.

MLA (9th ed.) Citation

N, Zimmermann, et al. "Enhanced Overall and Progression-free Survival in Advanced Melanoma Patients Undergoing Targeted Therapy Alongside Antithrombotic Treatment - Insights from a Multicenter Study Involving 1296 Patients from the Prospective Skin Cancer Registry ADOReg." European Journal of Cancer (Oxford, England : 1990), vol. 234, 2026, p. 116195, https://doi.org/10.1016/j.ejca.2025.116195.